SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Elder Pharma to foray into Japanese market by FY12-end

07 Dec 2011 Evaluate

Drug firm Elder Pharmaceuticals has planned to enter the Japanese pharma market during the current fiscal, as it had received accreditation from the Japanese Ministry of Health for its Patalganga facility. It has filed for new patents in these markets. So hopefully it should get these during the current financial year, which would open up another $500 million market .The Japanese pharmaceutical market is valued at about $70 billion. It has a plan to actually try to get about 1-2% of the market share. The company's plant at Patalganga manufactures active pharmaceutical ingredients (APIs).It has also developed two products going off-patent in the Japanese market in 2014. One of the products is from the central nervous system (CNS) category and the second is from the gastrointestinal (GI) segment. Elder has already filed a PCT patent (an international patent application) for one of the advanced intermediates for the Japanese market and is in talks with Japanese generic companies for supply contracts. Spending on generic drugs in Japan, the second-largest pharma market in the world, is on the rise and the government is targeting to increase the share of these low-cost alternatives to 30% of overall healthcare spending by 2013.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×